Literature DB >> 24685301

Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis.

Chia-Chi Wang1, Tsung-Cheng Hsieh2, Tai-Chung Tseng1, Pin-Chao Wang1, Ching-Sheng Hsu1, Hans Hsienhong Lin1, Li-Yu Wang3, Jia-Horng Kao4.   

Abstract

BACKGROUND/
PURPOSE: Ultrasonography has long been recognized as a useful tool for detecting hepatic steatosis in clinical practice. However, whether it can assess the severity of hepatic steatosis and which factors affect its diagnostic accuracy remain unclear.
METHODS: A total of 171 patients with various causes of hepatitis undergoing liver biopsies were retrospectively reviewed. The clinical, serologic data and ultrasonographical findings were recorded. Hepatic steatosis was graded as negative, mild, moderate, or severe by ultrasonography and histology. Histology was used as gold standard and the agreement rates were calculated.
RESULTS: Our data showed that the agreement rate of ultrasonography was 61.4% in assessing the severity of hepatic steatosis and 74.3% in diagnosing hepatic steatosis compared with histology (crude kappa=0.46 vs. 0.46). Using univariate analyses, body mass index and histology activity index score were associated with the agreement in assessing the severity of hepatic steatosis (p=0.008 and 0.035), whereas Ishak fibrosis score had a trend association (p=0.066). Multivariate analyses indicated that age, body mass index, and Ishak fibrosis score could affect the agreement (odds ratio=0.72, 0.89, and 1.41; 95% confidence interval=0.54-0.97, 0.83-0.97, and 1.1-1.8).
CONCLUSION: Ultrasonography could assess the severity of hepatic steatosis with moderate accuracy. Obese patients are difficult ultrasonographically. In addition, age and hepatic fibrosis could affect the performance of ultrasonography in assessing the severity of hepatic steatosis.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Keywords:  diagnostic accuracy; hepatic steatosis; histology; ultrasonography

Mesh:

Year:  2012        PMID: 24685301     DOI: 10.1016/j.jfma.2012.07.004

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  4 in total

Review 1.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

Review 2.  Confounding factors of non-invasive tests for nonalcoholic fatty liver disease.

Authors:  Janae Wentong Wai; Charmaine Fu; Vincent Wai-Sun Wong
Journal:  J Gastroenterol       Date:  2020-05-25       Impact factor: 7.527

3.  Validity of ultrasonography to assess hepatic steatosis compared to magnetic resonance spectroscopy as a criterion method in older adults.

Authors:  Emanuella De Lucia Rolfe; Soren Brage; Alison Sleigh; Francis Finucane; Simon J Griffin; Nick J Wareham; Ken K Ong; Nita G Forouhi
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

4.  Hepatorenal index for grading liver steatosis with concomitant fibrosis.

Authors:  Fabio Lucio Stahlschmidt; Jean Rodrigo Tafarel; Carla Martinez Menini-Stahlschmidt; Cristina Pellegrino Baena
Journal:  PLoS One       Date:  2021-02-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.